Asterias Biotherapeutics

Back to All Transactions

Asterias Biotherapeutics
For more information regarding this transaction contact:
  • Dave McDonald Investment Banking 612.326.1268
  • Rob Martin Investment Banking 612.260.5850

Lake Street is pleased to announce it served as a co-managing underwriter for Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading biotechnology company in the emerging field of regenerative medicine, in its public offering of 5,919,118 units at a price of $3.40 per unit. Gross proceeds totaled $20.1 million.

About Asterias Biotherapeutics

Headquartered in Menlo Park, CA, Asterias' core technologies center on stem cells capable of becoming all of the cell types in the human body, a property called pluripotency. Asterias plans to develop therapies based on pluripotent stem cells to treat diseases or injuries in a variety of medical fields having major unmet needs and without adequate therapies available.


Mike Townley
Head of Investment Banking


Email Mike

Dave McDonald
Head of Life Science Investment Banking


Email Dave


Tim Klein

Investment Banking


Email Tim


Rob Martin

Investment Banking


Email Rob


Steve Rickman

Investment Banking


Email Steve